Arthrosamid: A New Approach to Treating Patellofemoral Osteoarthritis
Arthrosamid® is an innovative intra-articular polyacrylamide hydrogel injection offering effective pain relief and improved mobility for patellofemoral osteoarthritis (PF-OA). Clinical studies demonstrate its safety and superior long-term benefits over hyaluronic acid, especially in patients under 70 with moderate osteoarthritis. This single injection restores joint lubrication and cushioning, reducing friction and enhancing knee function with minimal side effects. Arthrosamid presents a convenient and promising alternative to traditional treatments, supporting rehabilitation and long-term joint health. Ongoing research aims to optimize patient selection and assess durability, establishing Arthrosamid as a valuable therapy for managing PF-OA.
The Impact of Cartilage Deterioration on Knee Joint Instability and Quality of Life: Understanding Chondromalacia and Osteoarthritis
Learn about chondromalacia and knee osteoarthritis—two common causes of cartilage deterioration leading to knee pain and instability. This article explains how cartilage damage affects mobility, challenges in early diagnosis with imaging techniques like MRI, and treatment options ranging from physical therapy to surgery. Understand the importance of early detection and personalized care plans to protect knee health and maintain an active lifestyle.
